Eiger BioPharmaceuticals, Inc. EIGRQ
8.50
0.00
0.00%
as of 1 Oct
- Market cap
- $2.6M
- P/E
- 0.0×
Follow EIGRQ
Growth Flags
show if company had growth for consecutive years
| Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | — | — | — | — | — |
P/S ratio |
0.66 | 3.83 | 14.49 | — | — | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | — | — | — | — | — |
P/Operating CF |
(0.75) | (2.32) | (10.50) | — | — | — | — | — |
P/B ratio |
0.00 | 0.93 | 2.43 | — | — | — | — | — |
Price to Tangible BV |
0.00 | 0.93 | 2.43 | — | — | — | — | — |
EV/Sales |
4.24 | (0.53) | 9.80 | — | — | — | — | — |
EV/EBITDA |
0.00 | 0.08 | 0.00 | — | — | — | — | — |
EV/Operating CF |
(0.90) | 0.09 | (1.67) | — | — | — | — | — |
EV/FCF |
(0.90) | 0.09 | (1.67) | — | — | — | — | — |
Quick Ratio |
0.51 | 4.01 | 3.06 | 7.75 | 5.60 | 10.01 | 5.75 | 11.33 |
Current Ratio |
0.71 | 4.68 | 3.46 | 8.29 | 5.92 | 10.16 | 5.85 | 11.44 |
Net Debt/EBITDA |
(0.22) | 0.64 | 0.76 | 1.58 | 0.93 | 1.45 | 0.64 | 0.98 |
Debt/Assets |
105.91% | 33.39% | 25.15% | 22.13% | 29.41% | 25.01% | 35.20% | 24.25% |
Debt/Equity |
(2.84) | 0.73 | 0.44 | 0.33 | 0.55 | 0.38 | 0.67 | 0.36 |
Asset Turnover |
0.20 | 0.11 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.99 | 0.86 | 2.10 | 0.97 | 0.91 | 0.81 | 0.90 | 0.81 |
Capex/Depreciation |
0.28 | (0.35) | (0.13) | (0.34) | (25.00) | 0.38 | (13.00) | 3.22 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (367.00%) | (151.56%) | (40.51%) | (85.87%) | (114.16%) | (117.58%) | (134.24%) | (724.30%) | |
| (94.31%) | (78.51%) | (25.12%) | (52.31%) | (67.68%) | (72.10%) | (81.93%) | (142.00%) | |
ROIC |
(3,674.55%) | 0.00% | (312.68%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
505.89% | (103.94%) | (45.79%) | (53.37%) | (83.61%) | (56.95%) | (120.25%) | (85.14%) |
Average Days of Receivables |
38.92 | 47.34 | 77.44 | — | — | — | — | — |
Research and Development Expense of Revenue |
395.18% | 558.31% | 530.69% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
159.79% | 215.85% | 196.84% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
31.75% | 61.68% | 65.07% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(1.48) | 1.02 | 0.28 | — | — | — | — | — |
Graham Number |
106.11 | 0.00 | 0.00 | — | — | — | — | — |
Earnings Yield |
(723.58%) | (188.90%) | (19.29%) | — | — | — | — | — |
Free Cash Flow Yield |
(715.72%) | (161.30%) | (40.55%) | — | — | — | — | — |
Revenue per Share |
10.69 | 9.71 | 10.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(50.51) | (59.81) | (63.12) | (67.42) | (83.83) | (93.99) | (132.04) | (189.85) |
Capex per Share |
(0.16) | (0.24) | (0.20) | (0.28) | (0.63) | (0.31) | 0.54 | (0.29) |
Free Cash Flow per Share |
(50.67) | (60.05) | (63.32) | (67.69) | (84.46) | (94.30) | (131.51) | (190.14) |
Cash per Share |
17.24 | 71.29 | 78.58 | 137.47 | 125.19 | 221.04 | 143.77 | 299.68 |
Shareholders Equity per Share |
(9.80) | 39.85 | 64.05 | 101.40 | 74.43 | 146.68 | 77.50 | 203.61 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(9.80) | 39.85 | 64.05 | 101.40 | 74.43 | 146.68 | 77.50 | 203.61 |
Free Cash Flow |
(74.78) | (83.35) | (71.57) | (63.44) | (64.09) | (42.81) | (38.22) | (38.03) |
Working Capital |
(15.44) | 92.41 | 73.46 | 121.18 | 83.44 | 91.82 | 35.22 | 55.23 |
Capital Expenditures |
(0.23) | (0.34) | (0.22) | (0.26) | (0.47) | (0.14) | 0.16 | (0.06) |
Net Current Asset Value |
(15.44) | 52.71 | 49.36 | 89.25 | 51.73 | 65.99 | 22.13 | 40.50 |
EV/EBIT |
0.00 | 0.08 | 0.00 | — | — | — | — | — |
Capex to Sales |
0.01 | 0.03 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
(475.26%) | (717.71%) | (279.34%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Price to Operating Income |
0.00 | 0.00 | 0.00 | — | — | — | — | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
(1.33) | 1.40 | 2.93 | 1.08 | 0.03 | (2.23) | (0.15) | (0.24) |
Cash ROIC |
(144.29%) | (43.06%) | (37.28%) | (24.99%) | (35.20%) | (22.25%) | (48.43%) | (32.97%) |
Accounts Receivable Turnover |
9.19 | 6.24 | 0.00 | — | — | — | — | — |
Accounts Payable Turnover |
0.00 | 0.22 | 0.12 | 0.12 | 0.08 | 0.01 | 0.01 | 0.01 |
Inventory Turnover |
0.01 | 0.67 | 0.55 | 0.48 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
32,165.63 | 1,783.27 | 3,804.33 | 2,625.74 | 4,817.10 | 39,406.48 | 28,336.46 | 41,879.78 |
Days of Inventory on Hand |
23,664.17 | 566.87 | 1,279.70 | 52.63 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
1.72 | 2.16 | — | — | — | — | — | — |
Average Payables |
5.55 | 8.37 | 6.20 | 5.53 | 6.12 | 4.51 | 2.91 | 2.29 |
Average Inventory |
2.20 | 2.73 | 1.35 | 1.35 | — | — | — | — |
Average Assets |
79.48 | 123.27 | 135.00 | 124.37 | 103.79 | 72.67 | 51.81 | 33.16 |
Average Common Equity |
20.43 | 63.85 | 83.72 | 75.76 | 61.54 | 44.56 | 31.62 | 6.50 |
Columns are period end dates